biospecimen__admin__batch_number	345.53.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	557C5AA5-CC35-4DE5-BE85-AB1676CA3ABF
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-UB-A7MA-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-UB-A7MA-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-UB-A7MA-01A
biospecimen__bio__biospecimen_barcode_bottom	0160355309
biospecimen__bio__day_of_creation	13
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	10
biospecimen__bio__pathology_report_file_name	TCGA-UB-A7MA.82349CD5-39AA-42F8-80A1-B438B2300D09.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A33R
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.34
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-UB-A7MA
biospecimen__shared__patient_id	A7MA
clinical__ablation__ablation_performed_indicator	YES
clinical__ablation__ablation_type	Radiofrequency Ablation
clinical__ablation__bcr_ablation_barcode	TCGA-UB-A7MA-A63550
clinical__ablation__bcr_ablation_uuid	DD46242B-D31B-4035-9A6F-D3C7547F3F36
clinical__ablation__days_to_ablation_performed	295
clinical__ablation__days_to_embolization_performed	294
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Mitomycin C
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	Ethiodol
clinical__ablation__lesions_count	4
clinical__ablation__treatment_cycles_count	1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	95DCFA8E-9D1A-4BAB-A1E5-30D4D2C6CCBA
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.4
clinical__chol_lihc_shared__albumin_result_specified_value	4.0
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.4
clinical__chol_lihc_shared__creatinine_upper_limit	0.90
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	2008
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	140
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	62
clinical__clin_shared__bcr_followup_barcode	TCGA-UB-A7MA-F67133
clinical__clin_shared__bcr_followup_uuid	CA20DD09-AD0F-4FEA-85F6-0BC5EBD5FE44
clinical__clin_shared__day_of_form_completion	12
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	600
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R1
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	449
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__rx__bcr_drug_barcode	TCGA-UB-A7MA-D63552
clinical__rx__bcr_drug_uuid	30F9ADEB-3DCA-470C-B321-437EEFC241E7
clinical__rx__days_to_drug_therapy_start	485
clinical__rx__drug_name	gemcitabine
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocholangiocarcinoma (Mixed)
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2b
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a23fd611-d413-4ea7-9061-8caeba4b39ff
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-UB-A7MA-01A-11R-A33R-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	adc5a652-a9d5-4dce-88be-907244489590,a9dc958c-1fca-4138-9e5d-4db8393dbf1e,7ae629de-7f23-42e2-b283-317917f7c0fa
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - Counts,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.96
gdc__analytes__analyte_id	34da71f4-f3c5-4886-819e-0d3d9373016d
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	10179efc-a091-4119-8ec2-30db6269d674
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-26T21:13:06.104596-05:00,2016-05-26T21:13:05.712142-05:00,2016-05-26T21:13:05.913879-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	56fb6457-93fb-5e0b-ac1e-b84482478286
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1951
gdc__diagnoses__age_at_diagnosis	22843
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-22843.0
gdc__diagnoses__days_to_last_follow_up	848.0
gdc__diagnoses__diagnosis_id	0f3d62ed-4319-592e-ad99-734d01cdc101
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8180/3
gdc__diagnoses__primary_diagnosis	Combined hepatocellular carcinoma and cholangiocarcinoma
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	31.221303948576676
gdc__exposures__exposure_id	080d2f00-7d2d-5016-b0d8-f1fa586f5e3e
gdc__exposures__height	165.0
gdc__exposures__weight	85.0
gdc__file_id	2bcd75e9-d3dc-455f-8266-4ca4dc191561,8dd66061-3bf6-4437-a4ea-ea97db910f00,b104c407-b23a-47d0-90bf-7be02beb194f
gdc__file_name	21a0ef5f-24f5-45fe-ac84-deed4ef25329.FPKM.txt.gz,21a0ef5f-24f5-45fe-ac84-deed4ef25329.htseq.counts.gz,21a0ef5f-24f5-45fe-ac84-deed4ef25329.FPKM-UQ.txt.gz
gdc__file_size	508866,250668,511319
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	e8d3e5094d139f4fca25b7659984a59c,d767013453768d756022fc7c4b9e486d,75ce1afd7446aaa4a532f7bbfbc097f2
gdc__portions__is_ffpe	false
gdc__portions__portion_id	7d24f89b-5a5c-40de-9405-b6ad9b62acda
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	109
gdc__samples__initial_weight	500.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	82349CD5-39AA-42F8-80A1-B438B2300D09
gdc__samples__sample_id	b9f894f9-7e61-4604-968e-2592642fc53b
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	8beddb3b-c6df-491d-8cc5-35c67af26a96
gdc__submitter_id	21a0ef5f-24f5-45fe-ac84-deed4ef25329_fpkm,21a0ef5f-24f5-45fe-ac84-deed4ef25329_count,21a0ef5f-24f5-45fe-ac84-deed4ef25329_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	UB
gdc__tissue_source_site__name	UCSF
gdc__tissue_source_site__tissue_source_site_id	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c
gdc__treatments__treatment_id	1d4f1903-4986-5782-aeb3-e4fda6cc95f3
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:09:31.779+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/a23fd611-d413-4ea7-9061-8caeba4b39ff-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/a23fd611-d413-4ea7-9061-8caeba4b39ff-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5106591
manually_curated__local_md5	cad8cca71a7192b2d651599ad5021554
manually_curated__opengdc_download_date	2018-10-15T16:26:36.000366+02:00
manually_curated__opengdc_file_md5	74dc52c6c075efee93f92025292e5ca0
manually_curated__opengdc_file_size	1262075
manually_curated__opengdc_id	a23fd611-d413-4ea7-9061-8caeba4b39ff-geq
manually_curated__origin_file_size	5106591
manually_curated__origin_last_modified_date	Mon Oct 15 16:39:00 CEST 2018
manually_curated__origin_md5	cad8cca71a7192b2d651599ad5021554
manually_curated__tissue_status	tumoral
num	60483
